- Home
- QNTM
as 07-25-2025 4:00pm EST
Stocks
Quantum BioPharma Ltd is a biopharmaceutical company dedicated to building a portfolio of inventive assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, it is focused on the research and development of its lead compound, Lucid-MS. Lucid-MS is a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company maintains a portfolio of strategic investments through its wholly owned subsidiary, which represents loans secured by residential or commercial property.
| Founded: | 1998 | Country: | Canada |
| Employees: | N/A | City: | N/A |
| Market Cap: | 69.3M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 188.7K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -13.02 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.70 - $38.25 | Next Earning Date: | 08-13-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest QUANTUM BIOPHARMA LTD News
QNTM Breaking Stock News: Dive into QNTM Ticker-Specific Updates for Smart Investing
GlobeNewswire
a month ago
Quantum BioPharma Announces Private Placement
GlobeNewswire
a month ago
Quantum BioPharma Announces Private Placement of 12 Class A Multiple Voting Shares at a Price of $50 Per Share
MT Newswires
a month ago
Quantum Biopharma Licensee Unbuzzd Wellness Launches US$5 Million Capital Raise to Fund Growth
GlobeNewswire
a month ago
Quantum BioPharma Licensee Unbuzzd Wellness Inc. Launches $5 Million Reg D Capital Raise to Fund Growth and Path to Possible Initial Public Offering
Newsfile
a month ago
Singular Research Reports on Quantum BioPharma Ltd.'s Strategic Advances and Pipeline Progress
GlobeNewswire
a month ago
Quantum BioPharma Announces First Person with Multiple Sclerosis (MS) Scanned in Joint Study with Massachusetts General Hospital
GlobeNewswire
a month ago
Quantum BioPharma Announces Intention to Declare Special Dividend of Contingent Value Rights (CVRs) Linked to Future Litigation Settlement Proceeds
GlobeNewswire
2 months ago
Quantum BioPharma Clarifies It Has Not Changed Its Name
Compare QNTM vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "QNTM QUANTUM BIOPHARMA LTD - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.